Search Results - "Kuryk, Ł."

Tetrazole derivatives bearing benzodiazepine moiety—synthesis and action mode against virulence of Candida albicans by Staniszewska, M., Zdrojewski, T., Gizińska, M., Rogalska, M., Kuryk, Ł., Kowalkowska, A., Łukowska-Chojnacka, E.

“…Tetrazole and benzodiazepine derivatives attract widespread attention due to their remarkable pharmaceutical potential…”
Get full text

Genetic analysis of poliovirus strains isolated from sewage in Poland by Kuryk, Ł., Wieczorek, M., Diedrich, S., Böttcher, S., Witek, A., Litwińska, B.

“…The study describes genetic characterization of poliovirus (PV) strains isolated from sewage samples in Poland. The analyses were performed for the detection…”
Get full text

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment by Garofalo, M., Saari, H., Somersalo, P., Crescenti, D., Kuryk, L., Aksela, L., Capasso, C., Madetoja, M., Koskinen, K., Oksanen, T., Mäkitie, A., Jalasvuori, M., Cerullo, V., Ciana, P., Yliperttula, M.

“…Standard of care for cancer is commonly a combination of surgery with radiotherapy or chemoradiotherapy. However, in some advanced cancer patients this…”
Get full text

Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice by Garofalo, M., Villa, A., Rizzi, N., Kuryk, L., Rinner, B., Cerullo, V., Yliperttula, M., Mazzaferro, V., Ciana, P.

“…Extracellular vesicles (EVs), are naturally occurring cargo delivery tools with the potential to be used as drug vehicles of single agents or combination…”
Get full text

The detection of enteroviruses in sewage using Caco-2 cells by Wieczorek, Magdalena, Kuryk, Łukasz, Witek, Agnieszka, Diuwe, Anna, Litwińska, Bogumiła

“…The work presented here demonstrates the utility of Caco-2 cells to detect enteroviruses in sewage. Viruses were concentrated by beef extract elution and…”
Get full text

Multiple KRAS mutations detected by cancer related DNA in patients with resected pancreas adenocarcinoma during treatment with TG01/GM-CSF and gemcitabine (CT TG01-01) by Palmer, D., Møller, A.-S., Greenhalf, B., Ma, Y.T., Valle, J.W., Gjertsen, T.J., Kuryk, L.

Get full text

1083P A pilot study of engineered adenovirus ONCOS-102 in combination with pembrolizumab (pembro) in checkpoint inhibitor refractory advanced or unresectable melanoma by Shoushtari, A.N., Olszanski, A.J., Nyakas, M., Hornyak, T.J., Wolchok, J.D., Levitsky, V., Møller, A-S., Kuryk, L., Risberg Handeland, K., Jäderberg, M.

Get full text

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors by Chiaro, Jacopo, Antignani, Gabriella, Feola, Sara, Feodoroff, Michaela, Martins, Beatriz, Cojoc, Hanne, Russo, Salvatore, Fusciello, Manlio, Hamdan, Firas, Ferrari, Valentina, Ciampi, Daniele, Ilonen, Ilkka, Räsänen, Jari, Mäyränpää, Mikko, Partanen, Jukka, Koskela, Satu, Honkanen, Jarno, Halonen, Jussi, Kuryk, Lukasz, Rescigno, Maria, Grönholm, Mikaela, Branca, Rui M., Lehtiö, Janne, Cerullo, Vincenzo

“…Malignant pleural mesothelioma (MPM) is an aggressive tumor with a poor prognosis. As the available therapeutic options show a lack of efficacy, novel…”
Get full text

ONCOS-102 and pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma by Ponce Aix, S., Viteri, S., Bosch-Borrera, J., Kuryk, L., Hakonen, T., Vetrhus, S., Jäderberg, M., Paz-Ares, L.

Get full text

Enhanced anti-cancer vaccines with a new epitope improvement system by Capasso, C., Magarkar, A., Cervera Carrascon, V., Müller, M., Garofalo, M., Kuryk, L., Fusciello, M., Ylösmäki, E., Bunker, A., Cerullo, V.

Get full text

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial by Davidescu, Lavinia, Ursol, Grigoriy, Korzh, Oleksii, Deshmukh, Vikranth, Kuryk, Lesia, Nortje, Monja-Marie, Godlevska, Olga, Devouassoux, Gilles, Khodosh, Eduard, Israel, Elliot, Moussy, Alain, Mansfield, Colin D, Hermine, Olivier, Chanez, Pascal

“…Masitinib is an oral tyrosine kinase inhibitor that selectively targets mast cell activity and platelet-derived growth factor receptor (PDGFR) signaling, both…”
Get full text

Development of Oncolytic Adenovirus-Based Vaccine for Personalized Treatment of Malignant Mesothelioma by Chiaro, J, Antignani, G, Feola, S, Feodoroff, M, Martins, B, Cojoc, H, Ferrari, V, Ciampi, D, Ilonen, I, Rasanen, J, Mayranpaa, M, Partanen, J, Koskela, S, Kuryk, L, Russo, S, Fusciello, M, Hamdan, F, Rescigno, M, Gronholm, M, Branca, R, Lehtio, J, Cerullo, V

Get full text